Winer, I. S., Barve, M. A., Provencher, D. M., Sharma, M. R., Marsolais, C., Daigle, K., Douglas, L. M., Meric-Bernstam, F. (2025). Efficacy and safety data from Ph1b, dose optimization trial of two doses of TH1902 (sudocetaxel zendusortide), a novel SORT1-targeting peptide drug conjugate (PDC), administered weekly vs q3weekly in patients (pts) with advanced ovarian cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e15113